APA (7th ed.) Citation

Jayne, D., Rovin, B., Mysler, E., Furie, R., Houssiau, F., Trasieva, T., . . . Lindholm, C. (2023). Anifrolumab in lupus nephritis: Results from second-year extension of a randomised phase II trial. Lupus science & medicine, 10(2), e000910. https://doi.org/10.1136/lupus-2023-000910

Chicago Style (17th ed.) Citation

Jayne, David, et al. "Anifrolumab in Lupus Nephritis: Results from Second-year Extension of a Randomised Phase II Trial." Lupus Science & Medicine 10, no. 2 (2023): e000910. https://doi.org/10.1136/lupus-2023-000910.

MLA (9th ed.) Citation

Jayne, David, et al. "Anifrolumab in Lupus Nephritis: Results from Second-year Extension of a Randomised Phase II Trial." Lupus Science & Medicine, vol. 10, no. 2, 2023, p. e000910, https://doi.org/10.1136/lupus-2023-000910.